
2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU)
De La Motte Rouge, T., Pautier, P., Alexandre, J., Ray-Coquard, I., Cottu, P., Rodrigues, M., Follana, P., Floquet, A., Lortholary, A., Heudel, P.E., Combe, P., Joly, F., Suau, D., Maribas, D., LicourVolume:
51
Langue:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(16)31521-0
Date:
September, 2015
Fichier:
PDF, 72 KB
english, 2015